Predictive and prognostic value of PDL1 protein expression in breast cancer patients in neoadjuvant setting-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictive and prognostic value of PDL1 protein expression in breast cancer patients in neoadjuvant setting

Published:2019-03-13 Issue:6 Volume:20 Page:941-947
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Wu Ziping¹,Zhang Lei¹,Peng Jing¹,Xu Shuguang¹,Zhou Liheng¹,Lin Yanpin¹,Wang Yan¹,Lu Jinglu¹,Yin Wenjin¹,Lu Jinsong¹

Affiliation:

1. Department of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Funder

Foundation of Shanghai Municipal Commission of Health and Family Planning

National Natural Science Foundation of China

The Nurturing Fund of Renji Hospital

Science and Technology Commission of Shanghai Municipality

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2019.1583533

Reference27 articles.

1. Pathological Complete Response and Accelerated Drug Approval in Early Breast Cancer

2. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

3. Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer

4. 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial

5. Regulation of PD-L1: a novel role of pro-survival signalling in cancer

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis;Systematic Reviews;2024-04-04

2. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report;BMC Pulmonary Medicine;2024-02-22

3. Scoparone attenuates PD-L1 expression in human breast cancer cells by MKP-3 upregulation;Animal Cells and Systems;2024-02-09

4. Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: A systematic review and meta-analysis;2023-11-28

5. Clinical characteristics and survival analysis of HER2 negative breast cancer: AR and negative PD-L1 predict worse pathological complete response rate;2023-10-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3